Fraunhofer Institute for Translational Medicine and Pharmacology ITMP The board of trustees advises the Fraunhofer-Gesellschaft as well as the institute management and promotes the institute's contacts to organizations and industry.
The members of our board of trustees from industry, science and ministries are:
Prof. Dr. Iris Löw-Friedrich (Chairwoman)
Executive Vice President UCB Pharma GmbH, Monheim
Dr. h. c. Volker Bouffier
Hessian Prime Minister (ret.)
Prof. Dr. Klaus Cichutek
President of Paul Ehrlich Institute, Langen
Dr. Claudia Fleischer
Managing Director Roche Diagnostics GmbH, Mannheim / Penzberg
Dr. Rolf Greve
Behörde für Wissenschaft, Forschung, Gleichstellung und Bezirke (BWFGB), Hamburg
Prof. Dr. Stefan Hell
Max Planck Institute for Multidisciplinary Sciences, Göttingen
Dr. Claudia Jentzsch
Berlin-Chemie Menarini, Berlin
Dr. Joachim Kreuzburg
Chief Executive Officer Sartorius AG, Göttingen
Prof. Dr. Heyo Kroemer
Chief Executive Officer Charité - Universitätsmedizin Berlin, Berlin
Dr. Volker Lodwig
Roche Diagnostics GmbH (ret.), Mannheim
Dr. Ulrike Mattig
Hessisches Ministerium für Wissenschaft und Kunst (HMWK), Wiesbaden
Prof. Dr. Michael Popp
Bionorica SE, Neumarkt in der Oberpfalz
Prof. Dr. Enrico Schleiff
President of Goethe University, Frankfurt am Main
Prof. Dr. Blanche Schwappach-Pignataro
Dean of the Medical Faculty at the University Medical Center Hamburg-Eppendorf (UKE), Hamburg
Prof. Dr. Angelika Vollmar
Ludwig-Maximilian-Universität München, Munich
Dr. Marion Zerlin
Managing Director Research and Development, Sanofi-Deutschland GmbH